ATOS 1.2 (-6.25%)
US04962H5063BiotechnologyBiotechnology

Atossa Therapeutics (ATOS) Financial Metrics

This table shows a selected set of financial data points of Atossa Therapeutics (ATOS). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 0 0 0 110.95M 0 0 0 0 0 0
2022 -0.21 0 -2.49 67.11M -0.2 0 -20.79M -27.68M -26.96M 110.89M
2021 -0.18 0 -9.08 187.12M -0.22 0 -16.48M -20.5M -20.61M 136.38M
2020 -1.58 0 -0.6 10.74M -0.62 0 -11.58M -11.29M -17.83M 39.55M
2019 -2.03 0 -0.77 13.34M -1.32 0 -9.14M -17.21M -17.24M 12.58M
2018 -2.74 0 -0.37 4.24M -1.15 0 -9.07M -11.36M -11.4M 10.38M
2017 -8.33 0 -0.37 3.04M -1.32 0 -6.59M -7.8M -8.12M 7.22M
2016 -33.55 0 -0.5 3.21M -1.23 0 -5.38M -6.07M -6.37M 3.03M
2015 -99.79 0 -0.58 9.1M -1.75 1.76K -14.08M -15.49M -15.76M 3.72M
2014 -109.76 0 -2.35 34.37M -1.23 525.95K -10.9M -14.08M -14.66M 8.5M
2013 -125.37 0 -3.33 35.92M -1.15 632.56K -9.32M -10.31M -10.78M 6.34M
2012 -73.43 0 -9.56 48.57M -1.03 481.84K -4.03M -4.94M -5.08M 1.73M
2011 -67.96 0 0 0 -2.23 1.5K -3.63M -3.41M -3.44M 1.91M
2010 -17.38 0 0 0 0 0 -358.11K -1.08M -1.09M 10.25K
2009 0 0 0 0 0 0 0 0 0 0

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.